| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/21/2007 | EP1086225B1 Human tumour-derived polypeptide hormone phosphatonin |
| 02/21/2007 | EP1086117B1 Cloning and identification of the motilin receptor |
| 02/21/2007 | EP1034007B1 METHOD FOR THE PRODUCTION OF A ONE DOSE SYRINGE, COMPRISING A FREEZE-DRIED PROTEIN COMPOSITION, FOR ADMINISTERING A VOLUME LESS THAN 0.5 ml |
| 02/21/2007 | EP1003787B1 Agent for the treatment and/or prophylaxis of microcirculation disorders |
| 02/21/2007 | EP1000154B1 Identification of human cell lines for the production of human proteins by endogenous gene activation |
| 02/21/2007 | EP0999848B1 Chimeric proteins for the treatment of diabetes |
| 02/21/2007 | EP0954334B1 Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy |
| 02/21/2007 | EP0942996B8 Thrombolytic agents with antithrombotic activity |
| 02/21/2007 | EP0894004B2 Method for enhancing functional recovery of motor coordination, speech or sensory perception after central nervous system ischemia or trauma |
| 02/21/2007 | EP0871485B1 COMPOSITIONS AND METHODS FOR CATALYZING HYDROLYSIS OF HIV gp120 |
| 02/21/2007 | EP0815202B1 Human tissue inhibitor of metalloproteinase-4 |
| 02/21/2007 | EP0590126B1 Polypeptides having kinase activity, their preparation and use |
| 02/21/2007 | CN1918298A Pharmaceutical composition and method of treatment of human malignancies with arginine deprivation |
| 02/21/2007 | CN1918290A Screening method |
| 02/21/2007 | CN1918177A Novel glp-1 compounds |
| 02/21/2007 | CN1918175A Oligonucleotide compositions and methods for treating disease including inflammatory conditions |
| 02/21/2007 | CN1918131A Novel inhibitors of glutaminyl cyclase |
| 02/21/2007 | CN1917902A Use for interleukin-33 (il-33) and the il-33 receptor complex |
| 02/21/2007 | CN1917900A Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same |
| 02/21/2007 | CN1917899A Use of alkaline phosphatase for the detoxification of lps |
| 02/21/2007 | CN1917898A Biologically active substance of a vasoactive intestinal peptide for treating interstitial lung infections |
| 02/21/2007 | CN1917897A Composition and methods for modulating cns activity |
| 02/21/2007 | CN1917896A Surface protection of exposed biological tissues |
| 02/21/2007 | CN1917877A Combination of a farnesyl tranferase inhibitor with an antihormonal agent for the treatment of breast cancer |
| 02/21/2007 | CN1917871A Methods and compositions for the treatment of lipodystrophy |
| 02/21/2007 | CN1917861A Stabilised compositions of factor vii polypeptides |
| 02/21/2007 | CN1916167A Modulation of peroxisome proliferation-activated receptors |
| 02/21/2007 | CN1916023A Polypeptide in small molecule of endothelium inhibin, nucleotide sequence for encoding the polypeptide and complementary strand |
| 02/21/2007 | CN1916022A Gene correlative to cardiovascular pathology caused by diabetes, and usage |
| 02/21/2007 | CN1916021A Amido glycoside of sea pearl oyster, prepartion method, and usage |
| 02/21/2007 | CN1916020A Peptide antiangiogenic drugs |
| 02/21/2007 | CN1915427A Application of fusion protein of VEGF receptor for treating disease of eye |
| 02/21/2007 | CN1915424A Acellular pertussis vaccines and methods of preparation thereof |
| 02/21/2007 | CN1915344A Nutrient for cell growth, preparation method, and application of finished product in treating tumor, cardiovascular and cerebrovascular diseases |
| 02/21/2007 | CN1301268C Thrombus-resolving and anticoagulation double function fusion protein and use thereof |
| 02/21/2007 | CN1301265C Synthesized polypeptide and application |
| 02/21/2007 | CN1301263C Nucleotide sequence for anti HIV infection and preventing AIDS and use thereof |
| 02/20/2007 | US7179918 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 02/20/2007 | US7179901 Renal regulatory elements and methods of use thereof |
| 02/20/2007 | US7179898 Human vanilloid receptor-like receptor |
| 02/20/2007 | US7179894 Detection of preferential aptamer in sample; generate oligonucleotide, incubate with primer and polymerase, amplify and recover nucleotide sequences |
| 02/20/2007 | US7179893 Recombinant anti-TNF-α antibodies |
| 02/20/2007 | US7179890 Polypeptides as angiogenesis inhibitors |
| 02/20/2007 | US7179889 Propionicin T1 polypeptide, a bacteriocin from Propionibacterium thoenii |
| 02/20/2007 | US7179835 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 02/20/2007 | US7179833 Hydrogenation catalysts |
| 02/20/2007 | US7179796 Protein phosphatase 1B; oligonucleotide of 8-50 nucleobases targeted to a nucleic acid molecule encoding PTP1B; specifically hybridizes with and inhibits the expression of PTP1B. |
| 02/20/2007 | US7179795 Nucleic acids encoding chimeric proteins comprising BMP-2 and a proteinase inhibitor |
| 02/20/2007 | US7179794 Antibiotics; bactericides |
| 02/20/2007 | US7179793 Fish protein hydrolysates (Salmo or Oncorhynchus); for inhibiting angiotensin converting enzyme |
| 02/20/2007 | US7179792 Combination product of a 1,4-benzothiepine 1,1-dioxide compound with at least one other active ingredient and the use of the product |
| 02/20/2007 | US7179791 Inhibiting GS-FDH to modulate NO bioactivity |
| 02/20/2007 | US7179790 Brain natriuretic peptide |
| 02/20/2007 | US7179789 Peptide copper complex with corticosteroid, metronidazole, sulfacetamide, sulfur, and/or azelaic acid for topical administration; cosmetics |
| 02/20/2007 | US7179788 Synergistic mixtur eof glucangon-like peptide , in solid phase, and insulin solution, in liquid phase; antidiabetic agents; obesity |
| 02/20/2007 | US7179787 Methods of using human Zven proteins |
| 02/20/2007 | US7179786 Variants of the NK1 fragment of hepatocyte growth factor/scatter factor (HGF/SF) and their use |
| 02/20/2007 | US7179785 Compounds that bind to p185 and methods of using the same |
| 02/20/2007 | US7179784 Surfactant peptide nanostructures, and uses thereof |
| 02/20/2007 | US7179649 Culturing adipose stromal cells in a medium capable of supporting the growth of fibroblasts and differentiation inducing amounts of beta - glycerophosphate and ascorbic acid and/or ascorbic-2 phosphate |
| 02/20/2007 | US7179631 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog |
| 02/20/2007 | US7179629 For therapy and prophylaxis of cancer, diabetes, neurological disorders, cardiovascular disorders, musculo-skeletal disorders, inflammatory disorders, genitourological disorders, and respiratory disorders (e.g., asthma and COPD) |
| 02/20/2007 | US7179627 Cyclooxygenase variants and methods of use |
| 02/20/2007 | US7179622 Recombinant DNA formed by ligating; gene expression; suppressing proliferation; medicine/drugs |
| 02/20/2007 | US7179621 Pigment epithelium-derived factor: sequence of the PEDF gene |
| 02/20/2007 | US7179620 Elongation of fatty acids(ELF) polypeptides and carrier mixtures administered for prophylaxis of vision defects |
| 02/20/2007 | US7179617 Forming a convalent conjugate of a Factor IX peptide, removing X2 or a saccharyl subunit thereof from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety |
| 02/20/2007 | US7179610 Characterizing the existence of a disease state; particularly to the utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state |
| 02/20/2007 | US7179608 Therapeutic antiangiogenic compositions and methods |
| 02/20/2007 | US7179493 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 02/20/2007 | US7179490 Sustained release ionic conjugate |
| 02/20/2007 | US7179487 For use as biomaterials, such as contact lenses, soft tissue prostheses and controlled delivery systems for drugs |
| 02/20/2007 | US7179473 Attenuated pestiviruses |
| 02/20/2007 | US7179470 Hepatitis-C virus testing |
| 02/20/2007 | US7179466 Methods of treating rheumatoid arthritis by multiple administration of anti-TNF antibodies |
| 02/20/2007 | US7179465 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type 1 interferon |
| 02/20/2007 | US7179464 Immunoglobulin for use in the treatment and prevention of asthma |
| 02/20/2007 | US7179463 Treatment of alzheimer's disease |
| 02/20/2007 | US7179462 α (2) macroglobulin receptor as a heat shock protein receptor and uses thereof |
| 02/20/2007 | US7179461 Topical applying kinase to eye surface |
| 02/20/2007 | US7179459 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| 02/20/2007 | US7179458 Lactobacilli expressing biologically active polypeptides and uses thereof |
| 02/20/2007 | CA2346997C Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 02/20/2007 | CA2289979C Methods of modulating immune coagulation |
| 02/20/2007 | CA2284058C Diffusional implantable delivery system |
| 02/20/2007 | CA2251086C Glycopeptide compounds |
| 02/20/2007 | CA2218499C Chemokine binding protein and methods of use therefor |
| 02/20/2007 | CA2192512C Nm03 antibody materials and methods |
| 02/20/2007 | CA2151438C Thermostable trehalose-releasing enzyme, and its preparation and uses |
| 02/19/2007 | CA2516745A1 Botulinum toxin in treatment of clubfoot relapse |
| 02/19/2007 | CA2516742A1 Botulinum toxin in treatment of clubfoot |
| 02/17/2007 | CA2556287A1 Methods of treatment using vascular occlusion in combination with one or more therapies |
| 02/15/2007 | WO2007019545A2 Tissue protective peptides and uses thereof |
| 02/15/2007 | WO2007019532A2 Peptide aptamers that bind to the rep proteins of ssdna viruses |
| 02/15/2007 | WO2007019522A2 Reversal of adult onset disorders with granulocyte-colony stimulating factors |
| 02/15/2007 | WO2007019463A2 Methods of delivering therapeutics to the brain |
| 02/15/2007 | WO2007019453A2 Treatment of wounds using il-17b |
| 02/15/2007 | WO2007019426A2 A novel peptide involved in energy homeostasis |
| 02/15/2007 | WO2007019411A2 Peptides for diagnostic and therapeutic methods for celiac sprue |
| 02/15/2007 | WO2007019410A2 Mammalian obestatin receptors |